Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.0220
0.00 (0.00%)
Apr 6, 2026, 9:30 AM EST
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $102.12 thousand as of April 8, 2026. Its market cap has decreased by -97.35% in one year.
Market Cap
102.12K
Enterprise Value
-1.49M
Revenue
389.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from 27.05M to 102.12K, a decrease of -99.62%. That is a compound annual growth rate of -81.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 102.12K | -87.72% |
| Dec 31, 2025 | 831.75K | -77.44% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -33.55% |
| Dec 20, 2022 | 27.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ampio Pharmaceuticals | 173.20K |
| GB Sciences | 158.82K |
| CNBX Pharmaceuticals | 122.58K |
| Immunotech Laboratories | 114.99K |
| Synairgen | 110.27K |
| Innovation Pharmaceuticals | 105.75K |
| Affymax | 74.49K |
| Ocean Biomedical | 69.71K |